I reported previously (see here) on the PLX-R18 stem cell treatment for radiation sickness from Israel’s Pluristem. Animal trials by the US Department of Defense demonstrated that PLX-R18, administered before and after radiation exposure increased survival rates by 46-70%.

https://www.jpost.com/HEALTH-SCIENCE/Pluristem-gets-positive-results-from-radiation-treatment-trials-597271